HLA-A*0201 Positive Cells PresentФаза 2NCT06942442
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
Physician's Choice, Tebentafusp
23 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Sarcoma23 studies
HLA-A*0201 Positive Cells PresentФаза 2NCT06942442
Physician's Choice, Tebentafusp
Gastrointestinal Stromal TumorsФаза 2NCT05366816
Sunitinib, Regorafenib
LeiomyosarcomaФаза 2NCT07516925
Ivonescimab
AIDS-Related Kaposi SarcomaФаза 2NCT07539454
Biospecimen Collection, Chest Radiography, Computed Tomography, Nirogacestat
Metastatic ChondrosarcomaФаза 2NCT06176989
Enasidenib
RhabdomyosarcomaPhase 1NCT06865664Papers
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
High Grade SarcomaФаза 2NCT07650656
Electronic Health Record Review, Fluorescence Imaging, Fluorescence-Guided Surgery, Indocyanine Green
Metastatic LeiomyosarcomaФаза 2NCT06571734
Biospecimen Collection, Computed Tomography, Echocardiography, Multigated Acquisition Scan
SarcomaФаза 2NCT07741877
Lifileucel
Locally Advanced OsteosarcomaФаза 2NCT05019703
Atezolizumab, Cabozantinib
Advanced Alveolar Soft Part SarcomaФаза 2NCT05333458
Atezolizumab, Biopsy Procedure, Biospecimen Collection, Computed Tomography
Bone SarcomasФаза 2NCT07193550
Zanzalintinib
Desmoid TumorФаза 2NCT05949099
Nirogacestat, Cryoablation
Pediatric OsteosarcomaФаза 2NCT07428993
Cyclophosphamide, Fludarabine, Mesna, Apheresis
Kaposi SarcomaФаза 2NCT07308886
CYT107
Фаза 2Фаза 2NCT07283731
Zanzalintinib, Pembrolizumab
GIST - Gastrointestinal Stromal TumorФаза 2NCT07406633
KQB198, Imatinib (Gleevec)
Retroperitoneal SarcomaPhase 1/2NCT01659203
Proton or Photon RT for Retroperitoneal Sarcomas
SarcomaФаза 2NCT07089992
Pembrolizumab
ChondrosarcomaФаза 2NCT04040205
Abemaciclib
Sarcoma MetastaticФаза 2NCT07291297
Metformin Hydrochloride ER
Soft Tissue SarcomaФаза 2NCT06087861
External Beam Radiotherapy
Relapsed/Refractory Pediatric SarcomaPhase 1/2NCT05634369
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue